Mechanism of Late In-Stent Restenosis After Implantation of a Paclitaxel Derivate–Eluting Polymer Stent System in Humans
- 19 November 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (21) , 2649-2651
Abstract
Background— We recently reported delayed angiographic restenosis in 15 patients who received 7-hexanoyltaxol (QP2)–eluting polymer stents (QuaDS) for the treatment of in-stent restenosis. This study presents the histological findings of atherectomy specimens from a subset of these patients receiving implants. Methods and Results— Between October and December 2001, 5 patients treated with QuaDS-QP2 stents underwent directional coronary atherectomy at 11.2±1.0 months for recurrent in-stent restenosis. Restenotic lesion composition was assessed with special stains, immunohistochemistry with quantitative image analysis, and, in one specimen, transmission electron microscopy. Atherectomy specimens contained fibrin interspersed in a smooth muscle cell–rich neointima with proteoglycan matrix. In 2 of 5 specimens, large aggregates of macrophages and T-lymphocytes were noted. These areas of active inflammation demonstrated a relatively high proliferation index by Ki-67 antibody staining, whereas the proliferation index in smooth muscle cell–rich restenotic areas was low. Conclusion— Restenotic lesions from QuaDS-QP2–eluting stents at 12 months show persistent fibrin deposition with varying degrees of inflammation. These pathological changes, representing delayed healing, are usually observed up to only 3 months in human coronary arteries with stainless steel balloon-expandable stents. The nonreabsorbable polymer alone may have induced chronic inflammation.Keywords
This publication has 9 references indexed in Scilit:
- First clinical experience with paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis immediate and long-term clinical and angiographic outcomeACC Current Journal Review, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- First Clinical Experience With a Paclitaxel Derivate–Eluting Polymer Stent System Implantation for In-Stent RestenosisCirculation, 2002
- The Phytis Double-Coated Stent2001
- Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated StentCirculation, 2001
- Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary RestenosisCirculation, 2001
- Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six monthsJACC, 2000
- Arterial Paclitaxel Distribution and DepositionCirculation Research, 2000
- Pathology of Acute and Chronic Coronary Stenting in HumansCirculation, 1999